Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Letter
Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,384 | Dovepress* | 8,318+ | 998 | 9,316 | |
| PubMed Central* | 1,066 | 192 | 1,258 | ||
| Totals | 9,384 | 1,190 | 10,574 | ||
| *Since 21 February 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 14 | 1 | 0 | 0 | 6 | 7 |
View citations on PubMed Central and Google Scholar